PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.84%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
2.67%
Positive gross profit growth while AR is negative. John Neff would see a clear operational edge over the competitor.
4.38%
Positive EBIT growth while AR is negative. John Neff might see a substantial edge in operational management.
4.38%
Positive operating income growth while AR is negative. John Neff might view this as a competitive edge in operations.
-63.06%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-63.64%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-63.20%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-2.03%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.56%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-51.01%
Dividend reduction while AR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-15.63%
Negative OCF growth while AR is at 7.56%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-565.57%
Negative FCF growth while AR is at 15.38%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-42.08%
Negative 10Y revenue/share CAGR while AR stands at 226.56%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-42.08%
Negative 5Y CAGR while AR stands at 76.73%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-42.08%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-33.38%
Negative 10Y net income/share CAGR while AR is at 196.15%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-33.38%
Negative 5Y net income/share CAGR while AR is 129.17%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-33.38%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
75.99%
10Y equity/share CAGR above 1.5x AR's 24.95%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
75.99%
5Y equity/share CAGR above 1.5x AR's 2.75%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
75.99%
3Y equity/share CAGR above 1.5x AR's 31.02%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-27.31%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
59.61%
Inventory growth of 59.61% while AR is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
1.67%
Positive asset growth while AR is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-0.99%
We have a declining book value while AR shows 1.35%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
13.61%
We have some new debt while AR reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-2.69%
We cut SG&A while AR invests at 24.05%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.